- Home
- ERAS vs MITK Comparison
ERAS vs MITK Comparison
Compare ERAS & MITK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- MITK
- Stock Information
- Founded
- ERAS 2018
- MITK 1983
- Country
- ERAS United States
- MITK United States
- Employees
- ERAS N/A
- MITK N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- MITK Computer peripheral equipment
- Sector
- ERAS Health Care
- MITK Technology
- Exchange
- ERAS Nasdaq
- MITK Nasdaq
- Market Cap
- ERAS 432.6M
- MITK 411.7M
- IPO Year
- ERAS 2021
- MITK N/A
- Fundamental
- Price
- ERAS $1.16
- MITK $7.65
- Analyst Decision
- ERAS Strong Buy
- MITK Strong Buy
- Analyst Count
- ERAS 6
- MITK 4
- Target Price
- ERAS $4.83
- MITK $12.88
- AVG Volume (30 Days)
- ERAS 2.3M
- MITK 474.2K
- Earning Date
- ERAS 05-07-2025
- MITK 05-09-2025
- Dividend Yield
- ERAS N/A
- MITK N/A
- EPS Growth
- ERAS N/A
- MITK N/A
- EPS
- ERAS N/A
- MITK 0.10
- Revenue
- ERAS N/A
- MITK $172,420,000.00
- Revenue This Year
- ERAS N/A
- MITK $4.03
- Revenue Next Year
- ERAS N/A
- MITK $8.97
- P/E Ratio
- ERAS N/A
- MITK $79.41
- Revenue Growth
- ERAS N/A
- MITK 5.28
- 52 Week Low
- ERAS $1.01
- MITK $6.93
- 52 Week High
- ERAS $3.45
- MITK $14.32
- Technical
- Relative Strength Index (RSI)
- ERAS 41.47
- MITK 38.24
- Support Level
- ERAS $1.01
- MITK $7.46
- Resistance Level
- ERAS $1.29
- MITK $7.94
- Average True Range (ATR)
- ERAS 0.17
- MITK 0.38
- MACD
- ERAS 0.00
- MITK 0.03
- Stochastic Oscillator
- ERAS 31.25
- MITK 47.06
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About MITK Mitek Systems Inc.
Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.